Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | CA4 | P22748 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 3/20 | 0.41 |
| ▸ | CES2 | O00748 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | DAO | P14920 | 1/20 | 0.41 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
| ▸ | F10 | P00742 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Thiobenzoic Acid SCHEMBL28571982 | 0.94 | CA2 (0.48) | CA2CA4ALDH1A1MAPTL3MBTL1 | |
| Thiobenzoic Acid SCHEMBL28946274 | 0.94 | CA2 (0.48) | CA2CA4ALDH1A1MAPTL3MBTL1 | |
| Thiobenzoic Acid SCHEMBL10423562 | 0.94 | CA2 (0.48) | CA2CA4ALDH1A1MAPTL3MBTL1 | |
| Thiobenzoic Acid SCHEMBL28582374 | 0.94 | CA2 (0.55) | CA2CA4ALDH1A1MAPTL3MBTL1 | |
| Thiobenzoic Acid SCHEMBL6890939 | 0.94 | CA2 (0.48) | CA2CA4ALDH1A1MAPTL3MBTL1 | |
| Thiobenzoic Acid SCHEMBL29374102 | 0.94 | CA2 (0.55) | CA2CA4ALDH1A1MAPTL3MBTL1 | |
| Thiobenzoic Acid SCHEMBL6768673 | 0.94 | CA2 (0.48) | CA2CA4ALDH1A1MAPTL3MBTL1 | |
| Thiobenzoic Acid SCHEMBL20741484 | 0.94 | CA2 (0.48) | CA2CA4ALDH1A1MAPTL3MBTL1 | |
| Thiobenzoic Acid SCHEMBL22721212 | 0.94 | CA2 (0.48) | CA2CA4ALDH1A1MAPTL3MBTL1 | |
| Thiobenzoic Acid SCHEMBL11322372 | 0.94 | CA2 (0.48) | CA2CA4ALDH1A1MAPTL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1507765-A4 | METHODS AND COMPOSITIONS FOR TREATMENT OF CENTRAL AND PERIPHERAL NERVOUS SYSTEM DISORDERS AND NOVEL COMPOUNDS USEFUL THEREFOR | ISRAEL INST BIOLOG RES (IL) | 2006-11-02 | — | — | EP | claimed |
| CN-1662506-A | Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor | ISRAEL INST BIOLOG RES (IL) | 2005-08-31 | — | — | CN | claimed |
| EP-1507765-A2 | METHODS AND COMPOSITIONS FOR TREATMENT OF CENTRAL AND PERIPHERAL NERVOUS SYSTEM DISORDERS AND NOVEL COMPOUNDS USEFUL THEREFOR | ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH (IL) | 2005-02-23 | — | — | EP | claimed |
| WO-2003092580-A2 | METHODS AND COMPOSITIONS FOR TREATMENT OF CENTRAL AND PERIPHERAL NERVOUS SYSTEM DISORDERS AND NOVEL COMPOUNDS USEFUL THEREFOR | ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH (IL) | 2003-11-13 | — | — | WO | claimed |
| EP-4410804-B1 | NUCLEIC ACID STRAND CLEAVING METHOD, NUCLEIC ACID STRAND CLEAVING DEVICE, DOUBLE-STRANDED DNA PRODUCTION METHOD, AND DOUBLE-STRANDED DNA PRODUCTION DEVICE | JAPAN SCIENCE & TECH AGENCY (JP) | 2026-02-18 | — | — | EP | disclosed |
| US-20250163098-A1 | Nucleic Acid Strand Cleaving Method, Nucleic Acid Strand Cleaving Device, Double-Stranded DNA Production Method, and Double-Stranded DNA Production Device | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2025-05-22 | — | — | US | disclosed |
| EP-4410804-A1 | NUCLEIC ACID STRAND CLEAVING METHOD, NUCLEIC ACID STRAND CLEAVING DEVICE, DOUBLE-STRANDED DNA PRODUCTION METHOD, AND DOUBLE-STRANDED DNA PRODUCTION DEVICE | Japan Science and Technology Agency (JP) | 2024-08-07 | — | — | EP | disclosed |
| CN-118043333-A | Method and apparatus for cutting nucleic acid strand, and method and apparatus for producing double-stranded DNA | 国立研究开发法人科学技术振兴机构 | 2024-05-14 | — | — | CN | disclosed |
| WO-2023054391-A1 | NUCLEIC ACID STRAND CLEAVING METHOD, NUCLEIC ACID STRAND CLEAVING DEVICE, DOUBLE-STRANDED DNA PRODUCTION METHOD, AND DOUBLE-STRANDED DNA PRODUCTION DEVICE | 国立研究開発法人科学技術振興機構 | 2023-04-06 | — | — | WO | disclosed |
| US-9095565-B2 | Methods for treating blood disorders | PHOENICIA BIOSCIENCES, INC. (US) | 2015-08-04 | — | — | US | disclosed |
| US-20140301975-A1 | Methods for Treating Blood Disorders | PHOENICIA BIOSCIENCES INC (US) | 2014-10-09 | — | — | US | disclosed |
| US-8759378-B2 | Methods for treating blood disorders | PHOENICIA BIOSCIENCES, INC. (US) | 2014-06-24 | — | — | US | disclosed |
| US-20030225055-A1 | Processes for the preparation of carbapenem-type antibacterial agents | SANKYO COMPANY, LIMITED (JP) | 2003-12-04 | — | — | US | disclosed |
| WO-2003092580-A2 | METHODS AND COMPOSITIONS FOR TREATMENT OF CENTRAL AND PERIPHERAL NERVOUS SYSTEM DISORDERS AND NOVEL COMPOUNDS USEFUL THEREFOR | ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH (IL) | 2003-11-13 | — | — | WO | disclosed |
| EP-1338596-A1 | PROCESS FOR PRODUCING CARBAPENEM-TYPE ANTIBACTERIAL | Sankyo Company, Limited (JP) | 2003-08-27 | — | — | EP | disclosed |
| EP-1257558-A1 | METHODS FOR SYNTHESIS OF ALPHA-D-GAL (1- 3) GAL-CONTAINING OLIGOSACCHARIDES | Alchemia Pty Ltd (AU) | 2002-11-20 | — | — | EP | disclosed |
| US-6420415-B1 | Thiol compounds, their production and use | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2002-07-16 | — | — | US | disclosed |
| US-6358928-B1 | TREATING RESPIRATORY SYSTEM, RHEUMATIC AND GENETIC DISORDERS | ENZYME SYSTEMS PRODUCTS | 2002-03-19 | — | — | US | disclosed |
| EP-1132379-A1 | NOVEL THIOL DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2001-09-12 | — | — | EP | disclosed |
| WO-2001051499-A1 | METHODS FOR SYNTHESIS OF α-D-GAL (1→3) GAL-CONTAINING OLIGOSACCHARIDES | ALCHEMIA PTY LTD (AU) | 2001-07-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250163098-A1 | Nucleic Acid Strand Cleaving Method, Nucleic Acid Strand Cleaving Device, Double-Stranded DNA Production Method, and Double-Stranded DNA Production Device | DNASE1, NSUN2, UNG | CA2 717/4885CA4 1494/4885ALDH1A1 2979/4885 |
| US-20030225055-A1 | Processes for the preparation of carbapenem-type antibacterial agents | OXA1L, MRPL21, IRAK1 | CA2 2042/4885CA4 1096/4885ALDH1A1 1903/4885 |
| US-20140301975-A1 | Methods for Treating Blood Disorders | HBB, HBG1, HBG2 | CA2 2839/4885CA4 2116/4885ALDH1A1 642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.